Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DTX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,111
Award facts
- Contract value 100% obligated
- $32,111.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,111.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen (0.5 mL). This is a firm fixed-price, non-set-aside contract with a completion date of January 23, 2026, and was awarded on January 22, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 31, 2031, which enables the delivery of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, operating under its parent entity Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal pharmaceutical supply requirements through competitive bidding and maintains a robust portfolio of medical product deliveries across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Zepbound is a GLP-1 receptor agonist medication primarily used for weight management in eligible patients, reflecting the company's role in supplying contemporary pharmaceutical treatments to Defense Health Agency and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9DTX?
SPE2DR26F9DTX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9DTX worth?
The government has obligated $32,111 on SPE2DR26F9DTX.
Is contract SPE2DR26F9DTX an order under another contract?
Yes. SPE2DR26F9DTX is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DTX competed?
The extent of competition for SPE2DR26F9DTX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award